Biotech firm GRAIL to invest $103M for Durham facility, adding hundreds of jobs

GRAIL is a healthcare company whose mission is to detect cancer early. It is using the power of next-generation sequencing, population-scale clinical studies, and computer and data science to enhance the scientific understanding of cancer biology, and developĀ a multi-cancer early detection blood test